Renaissance Technologies’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.3K | Buy |
49,800
+300
| +0.6% | +$327 | ﹤0.01% | 3383 |
|
|
2025
Q1 | $61.9K | Buy |
49,500
+200
| +0.4% | +$250 | ﹤0.01% | 3268 |
|
|
2024
Q4 | $77.4K | Sell |
49,300
-400
| -0.8% | -$628 | ﹤0.01% | 3320 |
|
|
2024
Q3 | $94.9K | Buy |
49,700
+1,200
| +2% | +$2.29K | ﹤0.01% | 3266 |
|
|
2024
Q2 | $95.1K | Buy |
48,500
+4,700
| +11% | +$9.21K | ﹤0.01% | 3192 |
|
|
2024
Q1 | $104K | Buy |
43,800
+5,700
| +15% | +$13.5K | ﹤0.01% | 3360 |
|
|
2023
Q4 | $82K | Buy |
38,100
+5,200
| +16% | +$11.2K | ﹤0.01% | 3353 |
|
|
2023
Q3 | $69K | Buy |
32,900
+7,026
| +27% | +$14.7K | ﹤0.01% | 3330 |
|
|
2023
Q2 | $74K | Buy |
+25,874
| New | +$74K | ﹤0.01% | 3535 |
|